These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24384691)

  • 1. The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.
    Lissina A; Fastenackels S; Inglesias MC; Ladell K; McLaren JE; Briceño O; Gostick E; Papagno L; Autran B; Sauce D; Price DA; Saez-Cirion A; Appay V
    AIDS; 2014 Feb; 28(4):477-86. PubMed ID: 24384691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
    Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
    Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superimposed epitopes restricted by the same HLA molecule drive distinct HIV-specific CD8+ T cell repertoires.
    Sun X; Fujiwara M; Shi Y; Kuse N; Gatanaga H; Appay V; Gao GF; Oka S; Takiguchi M
    J Immunol; 2014 Jul; 193(1):77-84. PubMed ID: 24899498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.
    Almeida CA; van Miert P; O'Driscoll K; Zoet YM; Chopra A; Watson M; de Santis D; Witt C; John M; Claas FHJ; D'Orsogna LJ
    Cell Immunol; 2017 Jun; 316():32-40. PubMed ID: 28372798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.
    Berger CT; Frahm N; Price DA; Mothe B; Ghebremichael M; Hartman KL; Henry LM; Brenchley JM; Ruff LE; Venturi V; Pereyra F; Sidney J; Sette A; Douek DC; Walker BD; Kaufmann DE; Brander C
    J Virol; 2011 Sep; 85(18):9334-45. PubMed ID: 21752903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ TCR Bias and Immunodominance in HIV-1 Infection.
    Kløverpris HN; McGregor R; McLaren JE; Ladell K; Harndahl M; Stryhn A; Carlson JM; Koofhethile C; Gerritsen B; Keşmir C; Chen F; Riddell L; Luzzi G; Leslie A; Walker BD; Ndung'u T; Buus S; Price DA; Goulder PJ
    J Immunol; 2015 Jun; 194(11):5329-45. PubMed ID: 25911754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
    D'Offizi G; Gioia C; Corpolongo A; Martini F; Paganelli R; Volpi I; Sacchi A; Tozzi V; Narciso P; Poccia F
    Int J Immunopathol Pharmacol; 2007; 20(3):473-85. PubMed ID: 17880761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
    Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
    Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response.
    van Bockel DJ; Price DA; Munier ML; Venturi V; Asher TE; Ladell K; Greenaway HY; Zaunders J; Douek DC; Cooper DA; Davenport MP; Kelleher AD
    J Immunol; 2011 Jan; 186(1):359-71. PubMed ID: 21135165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.
    Migueles SA; Mendoza D; Zimmerman MG; Martins KM; Toulmin SA; Kelly EP; Peterson BA; Johnson SA; Galson E; Poropatich KO; Patamawenu A; Imamichi H; Ober A; Rehm CA; Jones S; Hallahan CW; Follmann DA; Connors M
    EBioMedicine; 2015 Jan; 2(1):46-58. PubMed ID: 26137533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes.
    Bennett MS; Joseph A; Ng HL; Goldstein H; Yang OO
    AIDS; 2010 Nov; 24(17):2619-28. PubMed ID: 20881472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B*14:02-Restricted Env-Specific CD8
    Leitman EM; Willberg CB; Tsai MH; Chen H; Buus S; Chen F; Riddell L; Haas D; Fellay J; Goedert JJ; Piechocka-Trocha A; Walker BD; Martin J; Deeks S; Wolinsky SM; Martinson J; Martin M; Qi Y; Sáez-Cirión A; Yang OO; Matthews PC; Carrington M; Goulder PJR
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.